{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:37:49Z","timestamp":1778848669792,"version":"3.51.4"},"reference-count":68,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Association for Cancer Research (AIRC)","award":["5 \u00d7 mille ID.9980"],"award-info":[{"award-number":["5 \u00d7 mille ID.9980"]}]},{"name":"Italian Association for Cancer Research (AIRC)","award":["ID.1426"],"award-info":[{"award-number":["ID.1426"]}]},{"name":"Italian Association for Cancer Research (AIRC)","award":["ID.24365"],"award-info":[{"award-number":["ID.24365"]}]},{"name":"Italian Association for Cancer Research (AIRC)","award":["ID.15426"],"award-info":[{"award-number":["ID.15426"]}]},{"name":"Italian Association for Cancer Research (AIRC)","award":["2014 n.16695"],"award-info":[{"award-number":["2014 n.16695"]}]},{"name":"Italian Association for Cancer Research (AIRC)","award":["RF-2021-12374376"],"award-info":[{"award-number":["RF-2021-12374376"]}]},{"name":"Italian Association for Cancer Research (AIRC)","award":["Ricerca Corrente 2022\u20132024"],"award-info":[{"award-number":["Ricerca Corrente 2022\u20132024"]}]},{"name":"AIRC and Fondazione CaRiCal","award":["5 \u00d7 mille ID.9980"],"award-info":[{"award-number":["5 \u00d7 mille ID.9980"]}]},{"name":"AIRC and Fondazione CaRiCal","award":["ID.1426"],"award-info":[{"award-number":["ID.1426"]}]},{"name":"AIRC and Fondazione CaRiCal","award":["ID.24365"],"award-info":[{"award-number":["ID.24365"]}]},{"name":"AIRC and Fondazione CaRiCal","award":["ID.15426"],"award-info":[{"award-number":["ID.15426"]}]},{"name":"AIRC and Fondazione CaRiCal","award":["2014 n.16695"],"award-info":[{"award-number":["2014 n.16695"]}]},{"name":"AIRC and Fondazione CaRiCal","award":["RF-2021-12374376"],"award-info":[{"award-number":["RF-2021-12374376"]}]},{"name":"AIRC and Fondazione CaRiCal","award":["Ricerca Corrente 2022\u20132024"],"award-info":[{"award-number":["Ricerca Corrente 2022\u20132024"]}]},{"name":"Associazione Italiana contro le Leucemie-Linfomi e Mieloma","award":["5 \u00d7 mille ID.9980"],"award-info":[{"award-number":["5 \u00d7 mille ID.9980"]}]},{"name":"Associazione Italiana contro le Leucemie-Linfomi e Mieloma","award":["ID.1426"],"award-info":[{"award-number":["ID.1426"]}]},{"name":"Associazione Italiana contro le Leucemie-Linfomi e Mieloma","award":["ID.24365"],"award-info":[{"award-number":["ID.24365"]}]},{"name":"Associazione Italiana contro le Leucemie-Linfomi e Mieloma","award":["ID.15426"],"award-info":[{"award-number":["ID.15426"]}]},{"name":"Associazione Italiana contro le Leucemie-Linfomi e Mieloma","award":["2014 n.16695"],"award-info":[{"award-number":["2014 n.16695"]}]},{"name":"Associazione Italiana contro le Leucemie-Linfomi e Mieloma","award":["RF-2021-12374376"],"award-info":[{"award-number":["RF-2021-12374376"]}]},{"name":"Associazione Italiana contro le Leucemie-Linfomi e Mieloma","award":["Ricerca Corrente 2022\u20132024"],"award-info":[{"award-number":["Ricerca Corrente 2022\u20132024"]}]},{"name":"Gilead fellowship program","award":["5 \u00d7 mille ID.9980"],"award-info":[{"award-number":["5 \u00d7 mille ID.9980"]}]},{"name":"Gilead fellowship program","award":["ID.1426"],"award-info":[{"award-number":["ID.1426"]}]},{"name":"Gilead fellowship program","award":["ID.24365"],"award-info":[{"award-number":["ID.24365"]}]},{"name":"Gilead fellowship program","award":["ID.15426"],"award-info":[{"award-number":["ID.15426"]}]},{"name":"Gilead fellowship program","award":["2014 n.16695"],"award-info":[{"award-number":["2014 n.16695"]}]},{"name":"Gilead fellowship program","award":["RF-2021-12374376"],"award-info":[{"award-number":["RF-2021-12374376"]}]},{"name":"Gilead fellowship program","award":["Ricerca Corrente 2022\u20132024"],"award-info":[{"award-number":["Ricerca Corrente 2022\u20132024"]}]},{"name":"Italian Ministry of Health 5 \u00d7 1000 funds","award":["5 \u00d7 mille ID.9980"],"award-info":[{"award-number":["5 \u00d7 mille ID.9980"]}]},{"name":"Italian Ministry of Health 5 \u00d7 1000 funds","award":["ID.1426"],"award-info":[{"award-number":["ID.1426"]}]},{"name":"Italian Ministry of Health 5 \u00d7 1000 funds","award":["ID.24365"],"award-info":[{"award-number":["ID.24365"]}]},{"name":"Italian Ministry of Health 5 \u00d7 1000 funds","award":["ID.15426"],"award-info":[{"award-number":["ID.15426"]}]},{"name":"Italian Ministry of Health 5 \u00d7 1000 funds","award":["2014 n.16695"],"award-info":[{"award-number":["2014 n.16695"]}]},{"name":"Italian Ministry of Health 5 \u00d7 1000 funds","award":["RF-2021-12374376"],"award-info":[{"award-number":["RF-2021-12374376"]}]},{"name":"Italian Ministry of Health 5 \u00d7 1000 funds","award":["Ricerca Corrente 2022\u20132024"],"award-info":[{"award-number":["Ricerca Corrente 2022\u20132024"]}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["5 \u00d7 mille ID.9980"],"award-info":[{"award-number":["5 \u00d7 mille ID.9980"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["ID.1426"],"award-info":[{"award-number":["ID.1426"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["ID.24365"],"award-info":[{"award-number":["ID.24365"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["ID.15426"],"award-info":[{"award-number":["ID.15426"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["2014 n.16695"],"award-info":[{"award-number":["2014 n.16695"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["RF-2021-12374376"],"award-info":[{"award-number":["RF-2021-12374376"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["Ricerca Corrente 2022\u20132024"],"award-info":[{"award-number":["Ricerca Corrente 2022\u20132024"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry of Health","award":["5 \u00d7 mille ID.9980"],"award-info":[{"award-number":["5 \u00d7 mille ID.9980"]}]},{"name":"Italian Ministry of Health","award":["ID.1426"],"award-info":[{"award-number":["ID.1426"]}]},{"name":"Italian Ministry of Health","award":["ID.24365"],"award-info":[{"award-number":["ID.24365"]}]},{"name":"Italian Ministry of Health","award":["ID.15426"],"award-info":[{"award-number":["ID.15426"]}]},{"name":"Italian Ministry of Health","award":["2014 n.16695"],"award-info":[{"award-number":["2014 n.16695"]}]},{"name":"Italian Ministry of Health","award":["RF-2021-12374376"],"award-info":[{"award-number":["RF-2021-12374376"]}]},{"name":"Italian Ministry of Health","award":["Ricerca Corrente 2022\u20132024"],"award-info":[{"award-number":["Ricerca Corrente 2022\u20132024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ncRNA"],"abstract":"<jats:p>A \u201cwatch and wait\u201d strategy, delaying treatment until active disease manifests, is adopted for most CLL cases; however, prognostic models incorporating biomarkers have shown to be useful to predict treatment requirement. In our prospective O-CLL1 study including 224 patients, we investigated the predictive role of 513 microRNAs (miRNAs) on time to first treatment (TTFT). In the context of this study, six well-established variables (i.e., Rai stage, beta-2-microglobulin levels, IGVH mutational status, del11q, del17p, and NOTCH1 mutations) maintained significant associations with TTFT in a basic multivariable model, collectively yielding a Harrell\u2019s C-index of 75% and explaining 45.4% of the variance in the prediction of TTFT. Concerning miRNAs, 73 out of 513 were significantly associated with TTFT in a univariable model; of these, 16 retained an independent relationship with the outcome in a multivariable analysis. For 8 of these (i.e., miR-582-3p, miR-33a-3p, miR-516a-5p, miR-99a-5p, and miR-296-3p, miR-502-5p, miR-625-5p, and miR-29c-3p), a lower expression correlated with a shorter TTFT, whereas in the remaining eight (i.e., miR-150-5p, miR-148a-3p, miR-28-5p, miR-144-5p, miR-671-5p, miR-1-3p, miR-193a-3p, and miR-124-3p), the higher expression was associated with shorter TTFT. Integrating these miRNAs into the basic model significantly enhanced predictive accuracy, raising the Harrell\u2019s C-index to 81.1% and the explained variation in TTFT to 63.3%. Moreover, the inclusion of the miRNA scores enhanced the integrated discrimination improvement (IDI) and the net reclassification index (NRI), underscoring the potential of miRNAs to refine CLL prognostic models and providing insights for clinical decision-making. In silico analyses on the differently expressed miRNAs revealed their potential regulatory functions of several pathways, including those involved in the therapeutic responses. To add a biological context to the clinical evidence, an miRNA\u2013mRNA correlation analysis revealed at least one significant negative correlation between 15 of the identified miRNAs and a set of 50 artificial intelligence (AI)-selected genes, previously identified by us as relevant for TTFT prediction in the same cohort of CLL patients. In conclusion, the identification of specific miRNAs as predictors of TTFT holds promise for enhancing risk stratification in CLL to predict therapeutic needs. However, further validation studies and in-depth functional analyses are required to confirm the robustness of these observations and to facilitate their translation into meaningful clinical utility.<\/jats:p>","DOI":"10.3390\/ncrna10050046","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:58:07Z","timestamp":1724417887000},"page":"46","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1479-8121","authenticated-orcid":false,"given":"Ennio","family":"Nano","sequence":"first","affiliation":[{"name":"Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4144-4292","authenticated-orcid":false,"given":"Francesco","family":"Reggiani","sequence":"additional","affiliation":[{"name":"SSD Gene Expression Regulation, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1573-7756","authenticated-orcid":false,"given":"Adriana Agnese","family":"Amaro","sequence":"additional","affiliation":[{"name":"SSD Gene Expression Regulation, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1978-4998","authenticated-orcid":false,"given":"Paola","family":"Monti","sequence":"additional","affiliation":[{"name":"Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5512-8106","authenticated-orcid":false,"given":"Monica","family":"Colombo","sequence":"additional","affiliation":[{"name":"Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-3260","authenticated-orcid":false,"given":"Nadia","family":"Bertola","sequence":"additional","affiliation":[{"name":"Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5097-6640","authenticated-orcid":false,"given":"Fabiana","family":"Ferrero","sequence":"additional","affiliation":[{"name":"Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"},{"name":"Department of Experimental Medicine, University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-7083","authenticated-orcid":false,"given":"Franco","family":"Fais","sequence":"additional","affiliation":[{"name":"Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"},{"name":"Department of Experimental Medicine, University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Bruzzese","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera Annunziata, 87100 Cosenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica Antonia","family":"Martino","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera Annunziata, 87100 Cosenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Vigna","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera Annunziata, 87100 Cosenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Puccio","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy"},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41121 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1219-0038","authenticated-orcid":false,"given":"Mariaelena","family":"Pistoni","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1954-5695","authenticated-orcid":false,"given":"Federica","family":"Torricelli","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"D\u2019Arrigo","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology (IFC-CNR), Section of Reggio Calabria, 89124 Reggio Calabria, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Greco","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Computer Science, University of Calabria, 87100 Cosenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology (IFC-CNR), Section of Reggio Calabria, 89124 Reggio Calabria, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9734-1017","authenticated-orcid":false,"given":"Carlo","family":"Adornetto","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Computer Science, University of Calabria, 87100 Cosenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5256-0726","authenticated-orcid":false,"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera Annunziata, 87100 Cosenza, Italy"},{"name":"Department of Pharmacy, Health and Nutritional Science, University of Calabria, 87036 Rende, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manlio","family":"Ferrarini","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Negrini","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2585-7073","authenticated-orcid":false,"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[{"name":"Gruppo Amici Dell\u2019Ematologia Foundation-GrADE, 42122 Reggio Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[{"name":"Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3335-1101","authenticated-orcid":false,"given":"Giovanna","family":"Cutrona","sequence":"additional","affiliation":[{"name":"Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","article-title":"Chronic lymphocytic leukaemia","volume":"391","author":"Hallek","year":"2018","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/asheducation-2017.1.329","article-title":"The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment","volume":"2017","author":"Gaidano","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2015-02-585042","article-title":"Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia","volume":"126","author":"Guieze","year":"2015","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/joim.12455","article-title":"Prognostic indices in chronic lymphocytic leukaemia: Where do we stand how do we proceed?","volume":"279","author":"Baliakas","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gonzalez-Gascon, Y.M.I., Munoz-Novas, C., Rodriguez-Vicente, A.E., Quijada-Alamo, M., Hernandez-Sanchez, M., Perez-Carretero, C., Ramos-Ascanio, V., and Hernandez-Rivas, J.A. (2021). From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct. Cancers, 13.","DOI":"10.3390\/cancers13081782"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ejh.13149","article-title":"Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment","volume":"101","author":"Gentile","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): A meta-analysis of individual patient data","volume":"17","author":"International","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.2019003453","article-title":"International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia","volume":"135","author":"Condoluci","year":"2020","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bjh.17074","article-title":"External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score","volume":"193","author":"Smolej","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ejh.13614","article-title":"Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol","volume":"106","author":"Morabito","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41375-022-01802-y","article-title":"Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: A study by ERIC in HARMONY","volume":"37","author":"Mansouri","year":"2023","journal-title":"Leukemia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.seminhematol.2024.03.001","article-title":"miRNA Biology in Chronic Lymphocytic Leukemia","volume":"61","author":"Bayraktar","year":"2024","journal-title":"Semin. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Balatti, V., and Croce, C.M. (2020). MicroRNA dysregulation and multi-targeted therapy for cancer treatment. Adv. Biol. Regul., 75.","DOI":"10.1016\/j.jbior.2019.100669"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Autore, F., Ramassone, A., Stirparo, L., Pagotto, S., Fresa, A., Innocenti, I., Visone, R., and Laurenti, L. (2023). Role of microRNAs in Chronic Lymphocytic Leukemia. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512471"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: Biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","article-title":"Non-coding RNAs in disease: From mechanisms to therapeutics","volume":"25","author":"Nemeth","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2008-11-189407","article-title":"microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification","volume":"113","author":"Stamatopoulos","year":"2009","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2010-01-263889","article-title":"microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival","volume":"116","author":"Rossi","year":"2010","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2006-12-062398","article-title":"Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia","volume":"109","author":"Fulci","year":"2007","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2008.377","article-title":"miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities","volume":"23","author":"Mraz","year":"2009","journal-title":"Leukemia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood-2011-11-394874","article-title":"MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia","volume":"119","author":"Mraz","year":"2012","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/1078-0432.CCR-13-2497","article-title":"microRNAome expression in chronic lymphocytic leukemia: Comparison with normal B-cell subsets and correlations with prognostic and clinical parameters","volume":"20","author":"Negrini","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","article-title":"The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia","volume":"17","author":"Klein","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","article-title":"MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia","volume":"124","author":"Cui","year":"2014","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2013-09-527234","article-title":"miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1","volume":"124","author":"Mraz","year":"2014","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/leu.2014.158","article-title":"Activation of the PI3K\/AKT pathway by microRNA-22 results in CLL B-cell proliferation","volume":"29","author":"Palacios","year":"2015","journal-title":"Leukemia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2012-03-415737","article-title":"The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state","volume":"120","author":"Tili","year":"2012","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41375-018-0230-x","article-title":"MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells","volume":"33","author":"Cerna","year":"2019","journal-title":"Leukemia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/leu.2014.344","article-title":"miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton\u2019s tyrosine kinase inhibition with Ibrutinib","volume":"29","author":"Guinn","year":"2015","journal-title":"Leukemia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/cam4.996","article-title":"The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia","volume":"6","author":"Guinn","year":"2017","journal-title":"Cancer Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2009-06-229211","article-title":"Karyotype-specific microRNA signature in chronic lymphocytic leukemia","volume":"114","author":"Visone","year":"2009","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.seminoncol.2016.02.015","article-title":"MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?","volume":"43","author":"Calin","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2119\/molmed.2013.00005","article-title":"Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia","volume":"19","author":"Papakonstantinou","year":"2013","journal-title":"Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3324\/haematol.2018.203828","article-title":"The involvement of microRNA in the pathogenesis of Richter syndrome","volume":"104","author":"Bayraktar","year":"2019","journal-title":"Haematologica"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/blood-2018-04-845115","article-title":"miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients","volume":"132","author":"Balatti","year":"2018","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hon.932","article-title":"Genomic profiling of Richter\u2019s syndrome: Recurrent lesions and differences with de novo diffuse large B-cell lymphomas","volume":"28","author":"Scandurra","year":"2010","journal-title":"Hematol. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11912-020-01001-x","article-title":"Richter Syndrome","volume":"23","author":"Condoluci","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.0800121105","article-title":"MiR-15a and miR-16-1 cluster functions in human leukemia","volume":"105","author":"Calin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/leu.2016.394","article-title":"Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: Implication for therapy","volume":"31","author":"Cutrona","year":"2017","journal-title":"Leukemia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1182\/bloodadvances.2021005726","article-title":"MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells","volume":"6","author":"Matis","year":"2022","journal-title":"Blood Adv."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/hon.2722","article-title":"Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients","volume":"38","author":"Lionetti","year":"2020","journal-title":"Hematol. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Monti, P., Lionetti, M., De Luca, G., Menichini, P., Recchia, A.G., Matis, S., Colombo, M., Fabris, S., Speciale, A., and Barbieri, M. (2020). Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: Results of the O-CLL1 study in early stage patients. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-75364-3"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Morabito, F., Tripepi, G., Moia, R., Recchia, A.G., Boggione, P., Mauro, F.R., Bossio, S., D\u2019Arrigo, G., Martino, E.A., and Vigna, E. (2021). Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.684621"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Morabito, F., Adornetto, C., Monti, P., Amaro, A., Reggiani, F., Colombo, M., Rodriguez-Aldana, Y., Tripepi, G., D\u2019Arrigo, G., and Vener, C. (2023). Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1198992"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/s41375-020-0747-7","article-title":"Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): A randomized phase 3 trial","volume":"34","author":"Herling","year":"2020","journal-title":"Leukemia"},{"key":"ref_56","first-page":"92","article-title":"Early intervention in asymptomatic chronic lymphocytic leukemia","volume":"19","author":"Muchtar","year":"2021","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1002\/ajh.24960","article-title":"Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases","volume":"93","author":"Gentile","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2016-07-728261","article-title":"Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients","volume":"128","author":"Gentile","year":"2016","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/leu.2015.333","article-title":"A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients","volume":"30","author":"Gentile","year":"2016","journal-title":"Leukemia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.2010.1919","article-title":"Association of a microRNA\/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia","volume":"305","author":"Fabbri","year":"2011","journal-title":"JAMA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood.2020005627","article-title":"miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: An axis affected by BCR inhibitors","volume":"137","author":"Sharma","year":"2021","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41417-021-00313-9","article-title":"Long noncoding RNA LINC01291 promotes the aggressive properties of melanoma by functioning as a competing endogenous RNA for microRNA-625-5p and subsequently increasing IGF-1R expression","volume":"29","author":"Wu","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"109390","DOI":"10.1016\/j.celrep.2021.109390","article-title":"MicroRNA miR-29c regulates RAG1 expression and modulates V(D)J recombination during B cell development","volume":"36","author":"Kumari","year":"2021","journal-title":"Cell Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gene.2018.12.076","article-title":"Investigation of the potential theranostic role of KDM5B\/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma","volume":"694","author":"Li","year":"2019","journal-title":"Gene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eaal1571","DOI":"10.1126\/scitranslmed.aal1571","article-title":"Microenvironmental regulation of the IL-23R\/IL-23 axis overrides chronic lymphocytic leukemia indolence","volume":"10","author":"Cutrona","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Vila-Casadesus, M., Gironella, M., and Lozano, J.J. (2016). MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151127"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"miRTarBase update 2022: An informative resource for experimentally validated miRNA-target interactions","volume":"50","author":"Huang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_68","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"}],"container-title":["Non-Coding RNA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2311-553X\/10\/5\/46\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:42:33Z","timestamp":1760110953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2311-553X\/10\/5\/46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ncrna10050046"],"URL":"https:\/\/doi.org\/10.3390\/ncrna10050046","relation":{},"ISSN":["2311-553X"],"issn-type":[{"value":"2311-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]}}}